July 2019 – IDIBELL

Jul 19 2019

EXTENDED DEADLINE — Expression of Interest (EoI) for Collaborative Projects on Regenerative Medicine

Regenerative Medicine Program / By Idibell

1.- Background The Centre for Regenerative Medicine of Barcelona (CMR[B]), together with the Biomedical Research Institute of Bellvitge (IDIBELL), at the behest of the Catalan Government(1), have launched the Program for advancing the Clinical Translation of Regenerative Medicine of Catalonia – P-CMR[C]. The fundamental mission of the P-CMR[C] is to advance the implementation of regenerative medicine strategies by conducting research […]

EXTENDED DEADLINE — Expression of Interest (EoI) for Collaborative Projects on Regenerative Medicine Read More »

Jul 18 2019

Researchers from IDIBELL confirm the validity of xenographic models for studies of methylation and chemoresistance in breast cancer

Leave a Comment / Cancer, Transformation and Metastasis / By Idibell

The new study identifies patterns of DNA methylation associated with breast cancer subtypes and response to docetaxel using PDX models

Researchers from IDIBELL confirm the validity of xenographic models for studies of methylation and chemoresistance in breast cancer Read More »

Jul 15 2019

An inflammatory diet correlates with colorectal cancer risk

Leave a Comment / Cancer, Colorectal Cancer / By Idibell

The risk of developing colorectal cancer for individuals that follow a pro-inflammatory diet is two times higher than usual

An inflammatory diet correlates with colorectal cancer risk Read More »

Jul 10 2019

Scientists Determine a mechanism that would allow treating more aggressive tumors

Leave a Comment / Cancer, Tumor and stromal chemoresistance / By Idibell

The study has proven the viability of this approach by studying in mice the evolution of metastatic colon tumors of human patients

Scientists Determine a mechanism that would allow treating more aggressive tumors Read More »

Jul 2 2019

Researchers at IDIBELL-ICO describe a new resistance mechanism to therapies that prevent the formation of blood vessels

Leave a Comment / Cancer, Tumour Angiogenesis / By Idibell

The mechanism does not activate the reduction of oxygen in the cells of the tumor, contrary to what common drugs, called anti-angiogenic, usually cause

Researchers at IDIBELL-ICO describe a new resistance mechanism to therapies that prevent the formation of blood vessels Read More »

Jul 1 2019

Quantum technology and cancer. Research and application in its detection and treatment

Leave a Comment / Cancer, Radiobiology & Cancer / By Idibell

The Centre de Cultura Contemporània of Barcelona (CCCB), with the collaboration of the Bellvitge Biomedical Research Institute (IDIBELL) and the program of Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), organized last 25th June 2019 a conference at the CCCB called “Quantum Technology and Cancer. Research and application in its detection and treatment.” In this interactive

Quantum technology and cancer. Research and application in its detection and treatment Read More »

EXTENDED DEADLINE — Expression of Interest (EoI) for Collaborative Projects on Regenerative Medicine

Researchers from IDIBELL confirm the validity of xenographic models for studies of methylation and chemoresistance in breast cancer

An inflammatory diet correlates with colorectal cancer risk

Scientists Determine a mechanism that would allow treating more aggressive tumors

Researchers at IDIBELL-ICO describe a new resistance mechanism to therapies that prevent the formation of blood vessels

Quantum technology and cancer. Research and application in its detection and treatment

Direct links

Follow us

Contact

Localization